Published in J Neurol Neurosurg Psychiatry on March 19, 2007
The autonomic effects of deep brain stimulation--a therapeutic opportunity. Nat Rev Neurol (2012) 0.91
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? Ther Adv Neurol Disord (2012) 0.82
Weight gain is associated with medial contact site of subthalamic stimulation in Parkinson's disease. PLoS One (2012) 0.82
The management of orthostatic hypotension in Parkinson's disease. Front Neurol (2013) 0.80
A systematic review of non-invasive brain stimulation therapies and cardiovascular risk: implications for the treatment of major depressive disorder. Front Psychiatry (2012) 0.78
Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study. Iran J Neurol (2015) 0.76
The association of heart rate variability with parkinsonian motor symptom duration. Yonsei Med J (2014) 0.76
Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease. Front Neurol (2017) 0.75
Syncope associated with subthalamic nucleus deep brain stimulation in a patient with Parkinson's disease. Case Rep Neurol Med (2013) 0.75
Effects of Deep Brain Stimulation on Autonomic Function. Brain Sci (2016) 0.75
Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease. Sci Rep (2017) 0.75
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Pathoanatomy of Parkinson's disease. J Neurol (2000) 2.16
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
Deep brain stimulation for the treatment of Parkinson's disease. J Clin Neurophysiol (2004) 1.36
Neurophysiological analysis of target-related sympathetic pathways--from animal to human: similarities and differences. Acta Physiol Scand (2003) 1.05
Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol (2003) 1.04
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Neurol Sci (1996) 0.97
Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. J Physiol (2002) 0.96
Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region. Brain Res Bull (2004) 0.94
Effect of L-dopa in young patients with hypertension. Angiology (1991) 0.90
Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol (2004) 0.89
Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J Neurol (2000) 0.87
Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction. Mov Disord (2005) 0.87
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease: preliminary physiological results. Neurol Sci (2001) 0.86
Effect of L-dopa on human muscle sympathetic nerve activity. Environ Med (1993) 0.83
Sympathetic activation due to deep brain stimulation in the region of the STN. Neurology (2005) 0.81
Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology (2002) 0.80
Isobolographic analysis of the interaction between fenoldopam and levodopa on arterial blood pressure of the rat. J Cardiovasc Pharmacol (2000) 0.80
Central and peripheral catecholamine mechanisms in circulatory control. Cardiology (1976) 0.79
The beta 2 receptor plays a role in the hypotensive effect of L-dopa. Acta Physiol Pharmacol Ther Latinoam (1995) 0.79
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin (2006) 4.78
Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc (2010) 3.92
Pseudoradicular and radicular low-back pain--a disease continuum rather than different entities? Answers from quantitative sensory testing. Pain (2007) 3.91
A new definition of neuropathic pain. Pain (2011) 3.57
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol (2010) 3.31
The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke (2011) 3.03
Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol (2008) 2.83
Interventional management of neuropathic pain: NeuPSIG recommendations. Pain (2013) 2.75
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain (2008) 2.65
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord (2006) 2.53
The Pharmacological Therapy of Chronic Neuropathic Pain. Dtsch Arztebl Int (2016) 2.45
Is CRPS I a neuropathic pain syndrome? Pain (2006) 2.40
Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ (2012) 2.32
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions. Dtsch Arztebl Int (2010) 2.27
Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med (2006) 2.26
The cerebral oscillatory network of parkinsonian resting tremor. Brain (2003) 2.22
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (2012) 2.11
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol (2010) 1.98
Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol (2012) 1.93
Introduction to the programming of deep brain stimulators. Mov Disord (2002) 1.93
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain (2012) 1.88
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain (2010) 1.84
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Proprioception and motor control in Parkinson's disease. J Mot Behav (2009) 1.79
Red flags for multiple system atrophy. Mov Disord (2008) 1.75
Complex regional pain syndrome: mystery explained? Lancet Neurol (2003) 1.75
Continuous theta-burst stimulation of the primary motor cortex in essential tremor. Clin Neurophysiol (2011) 1.73
Projected numbers of people with movement disorders in the years 2030 and 2050. Mov Disord (2011) 1.70
Sensory signs in complex regional pain syndrome and peripheral nerve injury. Pain (2011) 1.70
Cortical correlates of the basic and first harmonic frequency of Parkinsonian tremor. Clin Neurophysiol (2009) 1.65
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord (2014) 1.63
Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol (2008) 1.62
Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr (2010) 1.61
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord (2003) 1.58
Topical menthol--a human model for cold pain by activation and sensitization of C nociceptors. Brain (2004) 1.58
Deep brain stimulation: postoperative issues. Mov Disord (2006) 1.57
Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord (2010) 1.55
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg (2002) 1.51
Falls in frequent neurological diseases--prevalence, risk factors and aetiology. J Neurol (2004) 1.48
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. Pain (2015) 1.47
Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain (2006) 1.45
Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting. Pain (2015) 1.44
Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injury. Pain (2012) 1.43
Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J (2003) 1.43
Complex regional pain syndrome-a multifaceted disorder requiring multidimensional care: case study. J Pain (2007) 1.42
Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology (2012) 1.41
The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep (2009) 1.40
Do we need a third mechanistic descriptor for chronic pain states? Pain (2016) 1.39
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol (2012) 1.37
Translation of symptoms and signs into mechanisms in neuropathic pain. Pain (2003) 1.36
The motor system shows adaptive changes in complex regional pain syndrome. Brain (2007) 1.36
Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain (2010) 1.36
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin (2006) 1.34
Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord (2002) 1.34
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version. Ger Med Sci (2010) 1.30
Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging (2008) 1.28
Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain (2003) 1.28
Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype. Pharmacogenet Genomics (2011) 1.27
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol (2010) 1.24
How to assess motor impairment in writer's cramp. Mov Disord (2007) 1.24
Sensory symptom profiles and co-morbidities in painful radiculopathy. PLoS One (2011) 1.23
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin (2009) 1.23
Cortical involvement in the generation of essential tremor. J Neurophysiol (2007) 1.23
Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch Neurol (2004) 1.23